InvestorsHub Logo
Followers 22
Posts 3706
Boards Moderated 0
Alias Born 07/20/2006

Re: None

Tuesday, 06/11/2024 5:48:46 AM

Tuesday, June 11, 2024 5:48:46 AM

Post# of 183
Management has already stated such. However, it's still positive to see the following in print -

The company has now completed a majority of its multi-year payer contracts at significantly higher margins to COLL. To underscore this development and what the market is missing, if COLL were to run its business as-is and retire its debt, we estimate it could have a $1 billion net cash position by 2027. Furthermore, if their largest potential competitor (Teva Pharmaceuticals) stays out of the market, it could produce another $1 billion of free cash flow over the next three years. The current market capitalization is roughly $1 billion…”

https://finance.yahoo.com/news/collegium-pharmaceutical-inc-nasdaq-coll-211603220.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent COLL News